The effects of corticotrophin-releasing hormone, arginine vasopressin and their antagonists on ACTH release from perifused horse anterior pituitary cells.

This study investigates the inhibitory impacts of arginine vasopressin and corticotrophin-releasing hormone on the release of ACTH from horse pituitary cells. The main goal of the research was to gain more understanding of the CRH and AVP receptors in the horse pituitary and to determine if their combination could be blocked by antagonists.

Research Aims

• The central focus of this research revolves around understanding the role of Corticotropin-Releasing Hormone (CRH) and Arginine Vasopressin (AVP) in the regulated release of Adrenocorticotropic hormone (ACTH) in horses’ anterior pituitary cells.
• The study aimed to understand more about the character of the CRH and AVP receptors of the horse pituitary gland.
• The researchers intend to find out whether the responses induced simultaneously by AVP and CRH could be obstructed by employing antagonists.

Methodology

• The research involved a series of tests which involved applying pulse pulses of AVP, CRH, or a combination of both in intervals of 40 minutes.
• The pulses were given alternatingly with pulses that contained the secretagogues as well as the respective antagonist.
• In order to understand the effects of combined antagonists, the response to diminished secretagogue concentrations was tested (CRH, 0.03 nmol/l plus AVP, 2.5 nmol/l).

Findings and Conclusion

• Notably, the ACTH response to AVP was effectively inhibited over the dose range from 0.4-50 mumol/l by two antagonists, namely Phaa-D-Tyr(Et)2Lys6Arg3VP and d(CH2)5[Tyr(Me)2]AVP.
• The most effective suppression of the anticipated ACTH response to AVP was noted when the concentration of the antagonists were such: 10 mumol/l (to 28 +/- 2.1%) and 25 mumol/l (to 22 +/- 5.1%) respectively.
• Other salient findings found that the inhibition was not improved by pre-infusion compared to a bolus pulse. The antagonist Aaa-D-Try (Et)2Val4Abu6Arg8.9VP and non-peptide antagonist OPC-21268 yielded no inhibitory activity.
• The truncated abstract does not provide a full conclusion, but does highlight the potential effectiveness of certain antagonists in altering ACTH responses instigated by AVP and CRH within the context of horse pituitary cells.